Antigen-Specific Inverse Vaccination Strategies Using Particle Systems for Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Nanotechnology
• Vaccine Development

Background:

• Multiple sclerosis (MS) is a CNS autoimmune disease affecting millions globally, characterized by myelin sheath damage.
• Current MS treatments (DMTs) broadly suppress immunity, increasing infection risks.
• Inverse vaccination offers antigen-specific immune tolerance, targeting autoimmune responses without compromising overall immune function.

Purpose of the Study:

• To review particle-based inverse vaccination strategies for inducing immune tolerance in MS.
• To explore how engineered nanoparticles and microparticles deliver autoantigens for MS treatment.
• To highlight design principles for developing effective particle-based inverse vaccines.

Main Methods:

• Review of studies on particle-based delivery systems for MS inverse vaccination.
• Analysis of nano- and microparticle engineering for antigen delivery (e.g., myelin-derived autoantigens).
• Examination of strategies to induce regulatory T cells and tolerogenic antigen-presenting cells.

Main Results:

• Various particle platforms (PLGA, dextran, lignin, iron oxide, gold, liposomes) are engineered for MS inverse vaccination.
• Particle design influences antigen delivery and the induction of antigen-specific immune tolerance.
• These systems aim to suppress autoreactive immune responses while preserving protective immunity.

Conclusions:

• Particle-based inverse vaccination presents a promising antigen-specific therapeutic strategy for MS.
• Careful engineering of delivery systems is crucial for successful immune tolerance induction.
• Further research into design principles and challenges will advance particle-based MS vaccines.